Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Jan 24 2023

Full Issue

Opioid Use Disorder Costs Hospitals $95 Billion A Year

Axios reports that the cost of treating opioid misuse amounts to about 8% of all hospital expenditures, according to data from Premier Inc. AI Applied Sciences. In Kentucky, the governor promoted a program to help fight the drug epidemic. Meanwhile, USA Today covers the rise of xylazine in the illicit drug supply.

Axios: How Opioid Misuse Is Costing Health Systems

The addiction crisis is increasingly eroding health systems' finances, with the treatment of opioid use disorder (OUD) costing hospitals more than $95 billion a year, new data from Premier Inc. AI Applied Sciences shows. That's 7.86% of all hospital expenditures, according to the data, which was released first to Axios. (Goldman, 1/24)

AP: Ky. Gov Touts Program To Strengthen Drug Epidemic Fight

Kentucky communities can apply for certification through a program that evaluates the services being offered to residents seeking help for drug or alcohol addiction, Gov. Andy Beshear said. The governor announced the creation of the Recovery Ready Communities program last year. (1/24)

USA Today: What Is Xylazine? Animal Tranquillizer Shows Up In US Drug Supply

A new threat has emerged in the United States' illicit drug supply: an animal tranquilizer called xylazine. The drug is showing up in synthetic opioids, particularly fentanyl, leading to more overdoses and alarming side effects, according to the White House Office of National Drug Control. (Rodriguez, 1/24)

On marijuana and mushrooms —

Chicago Tribune: 'Alarming’ Jump In Illinois Kids Eating Marijuana Edibles Prompts Warning

Medical workers in Illinois are warning adults to keep marijuana edibles away from kids, after an “alarming” jump in the number of accidental consumptions. The number of exposures to edible cannabis among children 5 and younger from 2017-2021 reported in Illinois increased from 5 to 232 cases — a 4,500% increase. Most of the increase was during the pandemic years of 2020-2021. Illinois legalized recreational marijuana in 2020. (McCoppin, 1/23)

The Boston Globe: Mass. Lawmakers Propose Cannabis Reforms, Decriminalization Of Psychedelics

In advance of a late-Friday deadline for filing bills, state legislators last week submitted dozens of marijuana-related measures, including proposals to ban employers from firing workers over flunked THC tests, make it easier to wipe away old marijuana-related criminal charges, and require licensed cannabis facilities to allow workers to vote on unionizing. (Adams, 1/23)

Arizona Republic: Arizona Could Spend $30M To Study Psychedelic Mushrooms

Arizona would spend $30 million to research psychedelic mushrooms as a treatment for a host of medical conditions under a bipartisan proposal at the state Capitol. House Bill 2486 is groundbreaking not only because it would allow for such research, but also because it would lead to peer-reviewed research on the effects of natural psilocybin mushrooms, rather than a synthetic version of the drug commonly used in such studies. (Randazzo, 1/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF